spironolactone (Aldactone) is beneficial for heart failure has been all over the press
August 1999
The exciting new finding that spironolactone (Aldactone) is beneficial for heart failure has been all over the press.
Researchers saw such significant improvement that they stopped the study early so they could give the drug to ALL of the patients.
The New England Journal of Medicine also released the article early...over a month before it was scheduled to be published.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive